Previous issue | Volume 98 | ESPE2024

62nd Annual ESPE (ESPE 2024)

Liverpool, UK
16 Nov 2024 - 18 Nov 2024

Card image cap
The 62nd ESPE Annual Meeting will now be taking place in Liverpool, UK.

Poster Category 1

Multisystem Endocrinology

hrp0098p1-70 | Multisystem Endocrinology | ESPE2024

Two Cases of Type I Sialidosis and Literature Review

Ding Yuan

Objective: This study aims to compare the clinical and electrophysiological characteristics of two cases of type I sialidosis in Chinese children with previously reported cases, in order to elaborate the clinical and genetic features of type I sialidosis.Methods: Clinical investigations and genetic analyses were conducted on an 11-year-old girl primarily presenting with short stature, admitted in June 2020, and a 10 year...

hrp0098p1-71 | Multisystem Endocrinology | ESPE2024

Endocrine and metabolic comorbidities in juvenile-onset systemic lupus erythematosus

Jin Park Su , Bae Ahn Moon , Chul Jeong Dae , Kyu Suh Byung

Background and aims: Juvenile-onset systemic lupus erythematosus (JSLE) is a chronic autoimmune disease affecting individuals under 18, causing multi-system impairment. Patients with JSLE exhibit more severe disease when compared to patients with adult-onset SLE. This study aimed to evaluate the prevalence of endocrine and metabolic comorbidities in patients with JSLE, and analyze the factors associated with each comorbidity.Meth...

hrp0098p1-72 | Multisystem Endocrinology | ESPE2024

Serum nesfatin-1 and GLP-1 concentrations in adolescent patients with anorexia nervosa/obesity.

Blaska Małgorzata , Zachurzok Agnieszka , Gołąb-Jenerał Katarzyna , Ziora Katarzyna

Introduction: Anorexia nervosa (AN) is a psychiatric disorder affecting mainly adolescents and young women, characterized by a restriction of energy intake leading to malnutrition, serious medical complications and high mortality. Until now the etiology of AN remains unknown and seems to be multifactorial. Patients with AN develop endocrine disorders related to disturbances of energy metabolism. Nesfatin-1 and glucagon-like peptide-1 (GLP-1) are involved in th...

hrp0098p1-73 | Multisystem Endocrinology | ESPE2024

A young patient with paraganglioma due to a novel SDHB gene pathogenic variant.

Lymniati Christina , Sertedaki Amalia , Kyriakopoulos Georgios , Kanaka-Gantenbein Christina , Tsentidis Charalampos

Introduction: Paragangliomas are rare neuroendocrine neoplasms, that derive from the chromaffin cells of the neural crest. They originate from the extra-adrenal paraganglia and are divided into sympathetic and parasympathetic. They are classified into three different molecular clusters, depending on the underlying gene mutations, in any of at least 20 identified genes: cluster I Pseudo-hypoxia, cluster II Kinase signaling, cluster III Wnt signaling. Half of th...

hrp0098p1-74 | Multisystem Endocrinology | ESPE2024

10 Years’ experience in Omani cohort with variable presentation and genetically confirmed Wolfram Syndrome: Single Center Experience

AL AzkawiHanan , Nasser Nagla , AL Yahyai Moza , AL Madhani Shaima

Case 1: Twelve-year-old girl, presented with symptomatic hypoglycemia at the age of four. At six, she has type 1 diabetes mellitus (T1DM) started on insulin pump with excellent glycemic control. Genetic testing sent suspected MODY, revealed heterozygous variant in WFS1 gene, representing autosomal dominance inheritance. She screened for WFS associated disorder; negative.Case 2: Eighteen-year-old male with T1DM on insulin...

hrp0098p1-75 | Multisystem Endocrinology | ESPE2024

Endocrine Complications in Childhood Primary Brain Tumor Survivors: A Single Center Study

Chooprasertsuk Nuanpan , Wejaphikul Karn , Dejkhamron Prapai , Wiwattanadittakul Natrujee

Background: Primary brain tumors are the most prevalent solid tumors among children. Both the tumor itself and therapeutic interventions can lead to endocrine complications and metabolic consequences in survivors. However, current information on these complications in childhood brain tumor survivors (CBTS) in Thailand is limited.Objectives: This study aims to evaluate the prevalence of endocrine and metabolic complicatio...

hrp0098p1-76 | Multisystem Endocrinology | ESPE2024

The Significance of Clinical Examination in Diagnosing Genetic Diseases: An Infant with Williams-Beuren Syndrome

Katsoudas Sokratis , Willadara Gkamagie Stamatina , Polychroni Ioulia , Zosi Paraskevi , A. Stratakis Constantine

Objective: This case report emphasizes the significance of early clinical examination in a pediatric endocrinology clinic for the diagnosis of Williams-Beuren Syndrome (WBS). WBS is a rare genetic disorder typically caused by a deletion in the chromosomal region 7q11.23. This deletion results in the loss of 25-27 genes, including the elastin gene. It is characterized by growth delay, mild intellectual disability, behavioral issues, cardiac diseases (mainly sup...

hrp0098p1-77 | Multisystem Endocrinology | ESPE2024

An atypical presentation of McCune Albright syndrome

Bonnet Nicolas , Laurent Romain , Van-Nieuwenhuyse Jean-Paul , Becker Marianne , De Beaufort Carine , Schierloh Ulrike , Witsch Michael , Ghaddhab Chiraz

McCune-Albright syndrome (MAS) is a rare genetic disorder caused by somatic activating mutations in the GNAS gene. Depending on the embryonic stages at which the mutation occurs, the phenotype of MAS may vary widely. Typical features include polyostotic fibrous dysplasia, café-au-lait skin lesions and multiple endocrinopathies, most frequently a peripheral precocious puberty. More rarely, patients have a liver involvement. We report the case of a 2 years-old boy with a ...

hrp0098p1-78 | Multisystem Endocrinology | ESPE2024

The endocrine chameleon: expanding the phenotypic spectrum of pseudohypoparathyroidism 1A in infancy

Munteanu Martin , Resch Elisabeth , Iannou Phryne , Grasemann Corinna

Introduction: Inactivating PTH/PTHrP signaling disorders (iPPSD) including pseudohypoparathyroidism 1A (PHP1A) represent a heterogenous group of endocrine conditions. Associated phenotypes are complex and may consist of resistance to hormones and neurotransmitters as well as short stature, osteoma cutis and skeletal findings. Cases with unusual and poorly understood presentations attributed to PHP1A have been reported. PHP1A manifests at variable ages and the ...

hrp0098p1-79 | Multisystem Endocrinology | ESPE2024

Clinical Characteristics and Management Outcomes in Girls with McCune-Albright Syndrome: An Experience from a Tertiary Center

Dejkhamron Prapai , Unachak Kevalee , Wejaphikul Karn

Background: The clinical manifestations of McCune-Albright syndrome (MAS) are diverse, typically including fibrous dysplasia (FD), café au lait spots, and endocrine hyperfunction, most commonly gonadotropin-independent precocious puberty (GIPP). Management of endocrinopathies in MAS varies by the affected organs. Treatment options for GIPP include clinical observation, aromatase inhibitors (AIs), ketoconazole, medroxyprogesterone acetate, selective estr...